Effect of blood pressure con- trol on diabetic microvascular complications in patients with hyperten- sion and type 2 diabetes. Diabetes Care. 2000;23(suppl 2):B54 64. S9.6-20. Estacio RO, Jeffers BW, Hiatt WR, et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med. 1998;338:645 52. S9.6-21. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703 13. S9.6-22. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hyperten- sion: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755 62. S9.6-23. Reboldi G, Gentile G, Angeli F, et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients. J Hypertens. 2011;29:1253 69. S9.6-24. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957 67. S9.6-25. Brunstrom M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ. 2016;352:i717. S9.6-26. PerkovicV, RodgersA. Redefining blood-pressure targets SPRINT starts the marathon. N Engl J Med. 2015;373:2175 8. S9.6-27. Mancia G, Schumacher H, Redon J, et al. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation. 2011;124:1727 36. Wright JT Jr, Probstfield JL, Cushman WC, et al. ALLHAT find- ings revisited in the context of subsequent analyses, other trials, and meta-analyses. Arch Intern Med. 2009;169:832 42. 9.7. Metabolic Syndrome S9.7-1. Lim S, Eckel RH. 